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Betanodavirus-like particles enter host 
cells via clathrin-mediated endocytosis in a 
cholesterol-, pH- and cytoskeleton-dependent 
manner
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Abstract 
Betanodavirus, also referred to nervous necrosis virus (NNV), is the causative agent of the fatal disease, viral nervous 
necrosis and has brought significant economic losses in marine and freshwater cultured fish, especially larvae and 
juveniles. Here, we used an established invasion model with virus-like particle (VLP)-cells, mimicking orange-spotted 
grouper nervous necrosis virus (OGNNV), to investigate the crucial events of virus entry. VLP were observed in the 
perinuclear regions of Asian sea bass (SB) cells within 1.5 h after attachment. VLP uptake was strongly inhibited when 
cells were pretreated with biochemical inhibitors (chlorpromazine and dynasore) blocking clathrin-mediated endocy-
tosis (CME) or transfected with siRNA against clathrin heavy and light chains. Inhibitors against key regulators of cave-
olae/raft-dependent endocytosis and macropinocytosis had no effect on VLP uptake. In contrast, disruption of cellular 
cholesterol by methyl-β-cyclodextrin or reduction of cholesterol fluidity by Cholera toxin B subunit significantly 
decreased VLP entry. Furthermore, VLP entry is dependent on low pH and cytoskeleton, demonstrated by inhibitor 
(chloroquine, ammonia chloride, cytochalasin D, wiskostatin, and nocodazole) perturbation. Therefore, OGNNV VLP 
enter SB cells via CME depending on dynamin-2, cholesterol and its fluidity, low pH, and cytoskeleton. In addition, ten 
more cell lines were screened for VLP entry and VLP can only enter NNV-sensitive cells, GB and SSN-1, via CME, indicat-
ing that CME is the common endocytosis pathway for VLP. These results may provide the data for NNV entry without 
the influence of the viral genome, an ideal model for exploring the behaviour of betanodavirus in cells, and valuable 
references to vaccine development.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
To successfully infect host cells, viruses must first bind 
to cell surface proteins, carbohydrates, or lipids. Interac-
tions of viral structural proteins with cellular receptors 
are often specific and multivalent. These interactions 
activate the cellular signaling pathways that respond by 
internalizing the viruses using one of several endocytic 
mechanisms, including clathrin-mediated endocytosis 
(CME), caveolae/raft-dependent, non-clathrin-caveolae/
raft-dependent pathways, macropinocytosis, and a vari-
ety of other still poorly characterized mechanisms [1].
Clathrin-mediated endocytosis is the best character-
ized pathway of virus invasion and a classical endocytic 
mechanism, which most viruses use as the primary 
route of internalization [2]. A large number of viruses 
that enter host cells through CME have been identified, 
such as influenza virus [3], African swine fever virus [4], 
dengue virus serotype 2 [5], Singapore grouper iridovi-
rus (SGIV) [2] and so on. During this endocytic process, 
clathrin is assembled on the plasma membrane to form a 
clathrin-coated pit (CCP). CCP then invaginates to form 
a clathrin-coated vesicle (CCV) containing the internal-
ized viruses. During CCV budding, the membrane to be 
internalized and the size of the future vesicle are selected 
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before invagination during cargo recruitment, suggest-
ing that bending of a dynamic preassembled clathrin coat 
is involved in this process [6]. The vesicle subsequently 
sheds its clathrin coat and transports into acidic endo-
somal and lysosomal compartments and the trans-Golgi 
network [7]. A series of essential molecules, including 
Eps15, dynamin, and adapter protein AP2, are involved 
in this pathway. Chlorpromazine (CPZ), a biochemical 
inhibitor, can inhibit the clathrin-mediated uptake of 
viruses by preventing the assembly of CCP at the plasma 
membrane [8]. Low pH in the endosomes and lysosomes 
triggers viral penetration. Thus, the CME pathway is sen-
sitive to pH changes in these low-pH compartments and 
biochemical reagents, such as chloroquine and ammo-
nium chloride (NH4Cl), can inhibit the viral infection [9].
Another well-characterized pathway is caveolae/raft-
dependent endocytosis, an alternative to CME. In this 
mechanism, viruses bind to a specialized membrane 
domain composed of caveolin and associated with high 
levels of cholesterol and sphingolipids [10], called cave-
olae. Normally, caveolae on most cell surfaces exhibit 
little motility and dynamics. However, a signal cascade 
caused by the activation of tyrosine kinases can result in 
slow but efficient internalization [11]. Many reports show 
that endocytosis mediated by caveolae requires unique 
structural and signaling machinery [12]. Ligands inter-
nalized via caveolae will later be delivered to several dif-
ferent compartments. For example, cholera toxin (CTx) 
are delivered to caveosomes, the caveolin-1-positive, pH-
neutral endocytosis compartments, and then transported 
to the Golgi complex and the endoplasmic reticulum 
[13]. The use of caveolae/raft-dependent endocytosis for 
the entry of other viruses into host cells has been demon-
strated, such as simian virus 40 (SV40) [14], echovirus 1 
(EV1) [15], foot-and-mouth disease virus [16], infectious 
spleen and kidney necrosis virus (ISKNV) [17], among 
others.
Lipid rafts are specialized membrane microdomains 
that are enriched in sphingolipids, cholesterol, Src fam-
ily protein kinases, and glycosylphosphatidylinositol-
anchored proteins; thus, cholesterol is essential in lipid 
raft membranes [18]. For viruses, cholesterol-enriched 
membrane microdomains play an important role in mul-
tiple stages of virus life cycle that includes entry, fusion, 
replication, assembly and budding [19]. Because cave-
olae are associated with cholesterol-rich lipid rafts, dis-
ruption of membrane cholesterol severely inhibits virus 
entry via caveolae/raft-dependent endocytosis. How-
ever, accumulating evidence shows that cholesterol 
depletion also inhibits CME [1] whether in studies on 
virus entry or toxin and drug metabolism. For exam-
ple, transactivator of transcription (TAT)-modified 
and unmodified lipoplexes are mainly internalized via 
a cholesterol-dependent CME [20]. As for virus entry, a 
cholesterol-dependent CME is also identified in many 
studies, such as Japanese encephalitis virus (JEV) [21], 
adenovirus type 2 [22], chikungunya virus [23], Rhesus 
rhadinovirus [24], among others. Besides the presence of 
cholesterol, the fluidity of cholesterol or in other words 
the fluidity of the membrane is also important to virus 
entry. An increase in the membrane fluidity of lipid rafts 
was observed in the early stages of JEV infection [21]. 
Therefore, an increase in membrane fluidity will theo-
retically facilitate virus entry into the host cells, which 
was observed in human immunodeficiency virus type 1 
infection [25] and hepatitis C virus (HCV) infection [26]. 
However, conflicting results have also been observed. 
Phenothiazines are drugs that inhibit HCV entry by 
increasing the fluidity of cholesterol-rich membranes 
[27]. Nevertheless, virus entry and internalization are 
sensitive to the plasma membrane fluidity. To decrease 
the membrane fluidity, CTx is normally used to bind 
sphingolipid GM1, reducing the diffusion of other lipid 
molecules in the same membrane [28].
Virus-like particles (VLP) are mono- or multi-protein 
structures that mimic the organization and conforma-
tion of authentic native viruses but lack the viral genome, 
potentially yielding safer vaccine candidates than inactive 
viruses [29]. Attenuation or inactivation is not required 
for VLP vaccine and this step is particularly important 
since epitopes are commonly modified by inactivation 
treatments [30]. Compared with individual proteins or 
peptides, VLP present conformational epitopes similar to 
the native virus [31]. Owing to the similarity of surface 
protein structure to the native viruses, corresponding 
VLP are used as substitutes for studies of highly virulent 
viruses [32] or as a model for antiviral drug screening 
[33]. Since the entry process is based on the interac-
tion of viral structural proteins and cellular components 
without the participation of the viral genome, it is rea-
sonable to use VLP to study the virus entry process with 
the advantage of easy manipulation [34]. The   indirect 
immunofluorescence assay (IFA) can be used to visualize 
viral structural proteins during virus entry and trafficking 
in the target cells. In contrast to infectivity or reporter 
detection, the assay using IFA to detect VLP location 
after VLP entry does not rely on the expression of any 
viral and reporter genes, but instead directly visualizes 
the accumulation of viral particles in cells as an indicator 
of successful viral entry and trafficking in cells [35].
The Nodaviridae family contains two genera: Betano-
davirus, the viruses in  which predominantly infect fish, 
and Alphanodavirus, the viruses in which mostly infect 
insects [36]. Betanodaviruses are the causative agents for 
disease of viral nervous necrosis (VNN), an infectious 
neuropathological condition characterized by necrosis 
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of the central nervous system, including the brain and 
retina, which shows clinical signs that include abnor-
mal swimming behaviour and darkening of the fish [37]. 
VNN is capable of causing massive mortality in the lar-
vae and juvenile populations of more than 40 marine and 
freshwater teleost species [38], suggesting their strong 
infectivity to a wide range of hosts. Compared with the 
intensive studies on the alphanodavirus [39], viruses in 
another genus in the same family, research on the entry 
process of betanodavirus are still a rarity. Current stud-
ies have only showed that the cellular heat shock cognate 
protein 70 (HSP70) [40] and cell surface sialic acid [41] 
are essential for NNV infection, endosomal acidification 
is required for effective infection [42], and NNV entry 
utilizes both micro- and macropinocytosis pathways [41]. 
Therefore, investigating the mechanism of NNV entry 
into host cells is essential and critical to understanding 
the true behaviour of betanodavirus infection. The capsid 
protein of orange-spotted grouper nervous necrosis virus 
(OGNNV) and dragon grouper nervous necrosis virus 
(DGNNV) expressed in Escherichia coli also forms VLP 
that morphologically resembles native virus [43, 44]. The 
VLP can block the attachment of the native virus to the 
surface of striped snakehead (SSN-1) cells, thus restrict-
ing virus infection [45] or even enter sea bass (SB) cells at 
the same dynamics as that of native virus [46]. This phe-
nomenon suggests that the outer shell of VLP is structur-
ally indistinguishable from native virus and recognized 
by the putative cellular receptor(s).
In the present study, we used VLP originated from 
OGNNV (RBS) and SB cells as a model for virus entry to 
examine the pathway and important factors of betano-
davirus entry into host cells using perturbation, such as 
biochemical inhibition or siRNA silencing, and IFA to 
detect the route of VLP entry. C-terminal green fluores-
cent protein-tagged VLP (CGV) was also used to locate 
VLP in cells in real-time and study membrane fluidity. In 
addition, we screened other types of cells for VLP entry 
ability. Our results not only contribute greatly to under-
standing betanodavirus entry and pathogenesis but also 
provide new insights into vaccine design.
Materials and methods
Cell culture
The SB fibroblast cell line derived from Lates calcarifer 
larvae was obtained from Temasek Life Sciences Labo-
ratory of the National University of Singapore [44]. SB 
cells are sensitive to OGNNV and were used for the cell 
entry assay. The cells were grown in minimal essential 
medium (MEM, Gibco, USA) supplemented with 10% 
fetal bovine serum (FBS, Gibco). SSN-1 derived from 
Channa striatus larvae and GB derived from the brain 
of Epinephelus coioides were grown in L15 and DMEM 
(Gibco) respectively. Mandarin fish fry-1 (MFF-1) cells 
derived from Siniperca chuatsi fry [47], fathead min-
now (FHM) cells derived from Pimephales promelas, 
and epithelioma papulosum cyprini (EPC) cells derived 
from Cyprinus carpio were grown in DMEM and M199 
respectively. All fish cell lines were grown at 26  °C sup-
plemented with 10% FBS. SF9 derived from Spodoptera 
frugiperda and Drosophila Schneider 2 (S2) derived from 
Drosophila melanogaster were grown at 28 °C in Grace’s 
Insect Medium and Schneider’s Insect Medium (Gibco) 
supplemented with 10% FBS respectively. Hela, 293T and 
baby hamster kidney (BHK) cells were grown at 37 °C in 
DMEM supplemented with 10% FBS. For IFA or ELISA 
following biochemical inhibitor analysis, the cells were 
seeded on coverslips in 12-well plates or cultured in 
96-well plates for 14 or 18 h to achieve 70% confluence.
Antibodies, reagents, and biochemical inhibitors
A polyclonal antibody, mouse anti-VLP sera (total immu-
noglobulin), were produced from our laboratory. Alexa 
Fluor 488 donkey anti-mouse IgG, Alexa Fluor 594 don-
key anti-mouse IgG, and Alexa Fluor 488 donkey anti-
goat IgG was from Molecular Probes (Invitrogen, USA). 
DAPI, Goat anti-biotin antibody, chlorpromazine (CPZ), 
dynasore, methyl-β-cyclodextrin (MβCD), cholesterol, 
genistein, wortmannin, Cholera toxin B subunit (CTB), 
ML-7, NSC23766, rottlerin, IPA-3, chloroquine, ammo-
nia chloride (NH4Cl), cytochalasin D (CytD), wiskosta-
tin, and nocodazole were purchased from Sigma-Aldrich 
(Merck, USA). All drugs were dissolved, prepared, used 
in certain concentrations and stored at the indicated tem-
perature as shown in Table 1.
Cytotoxicity assay
To optimize the working concentration of the inhibi-
tors, the cytotoxicity of the drugs to SB cells were evalu-
ated. SB cells grown in 96-well plates were treated with 
the inhibitors at different concentrations for 4  h. Then 
cell viability was assayed using CellTiter 96® AQueous 
One Solution Cell Proliferation Assay (Promega, USA) 
according to the manufacturer’s instructions. The con-
centration of all drugs employed in this study did not 
cause significant adverse effects on cell viability (Table 1).
VLP production and cell entry assays
OGNNV VLP, including the native form of VLP (RBS) 
and the modified VLP (CGV), were produced as 
described [44]. In brief, a volume of 80 mL seed culture 
grown overnight at 37  °C was inoculated equally into 
8 flasks of 1  L LB-broth medium supplemented with 
100 μg/mL ampicillin. When the cell density reached an 
OD600 of 0.3–0.4, the culture was cooled down to 30 °C 
for RBS or 23 °C for CGV and 0.9 mM IPTG was added 
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for induction. After induction of 2.5 h at 30  °C for RBS 
or 8 h at 23 °C for CGV, cells were harvested by centrifu-
gation and resuspended in 100 mL lysis buffer, followed 
by sonication and centrifuged at 40 000 ×  g for 20 min. 
The supernatant was ultracentrifuged at 250 000 × g for 
1 h against a 30% sucrose cushion. The pellet was resus-
pended in 4 mL of PBS (pH 8.0) and further purified by 
ultracentrifugation against a 10–40% (w/w) sucrose gra-
dient at 250 000 × g for 3 h. The fractions containing fine 
structured and highly pure VLP were diluted with PBS 
and ultracentrifuged at 250  000 ×    g for 1  h to remove 
the sucrose. The pellets were resuspended with PBS and 
the VLP (RBS or CGV) were verified by Transmission 
Electron Microscopy (JOEL JEM-1400, Japan). Purified 
VLP were applied to SDS-PAGE and BCA Protein Assay 
Kit (Thermo, USA) to determine the concentration and 
stored at −80 °C until use.
Virus-like particles entry (invasion) assays were per-
formed using SB or other indicated cells as described 
[46]. In brief, the cells were seeded on coverslips in 
12-well plates or cultured in 96-well plates for 18 or 24 h 
to achieve 70% confluence, pretreated with the indi-
cated inhibitors at the indicated temperature (26  °C for 
fish cells, 28  °C for insect cells, and 37  °C for mamma-
lian cells) and concentration (Table 1) for 1 h, and then 
incubated with RBS or CGV in the presence of the inhibi-
tors for 1 h on ice. After that, the cells were washed three 
times with pre-cooling PBS, shifted to 28  °C to start 
entry, and visualized directly by fluorescent microscopy 
for CGV entry kinetics, or fixed for IFA followed by fluo-
rescent microscopy, or collected for ELISA at the indi-
cated times. In the untreated (positive) or mock-infected 
(negative) controls, the cells were subjected to no inhibi-
tor treatment or no VLP incubation respectively. The 
entry assay of each inhibitor was repeated at least three 
times.
Gene cloning, siRNA generation and cell transfection
According to the clathrin sequences available from 
fish (accession num: HQ441139, XM_010735171, 
XM_010735171, XM_014407499), degenerated prim-
ers for clathrin heavy chain (CHC) and clathrin light 
chain (CLC) were respectively designed and synthesized 
(Table  2). Total RNA was extracted from SB cells using 
RNeasy Mini Kit (Qiagen, Germany) and reverse-tran-
scribed into cDNA using the First Strand cDNA Synthe-
sis Kit (Toyobo, Japan) according to the manufacturer’s 
instructions. cDNA from SB cells were used as the tem-
plate for PCR to amplify the conserved sequence of 
clathrin and the PCR products were sequenced to con-
firm the partial CDS. Based on the CDS, RACE primers 
were designed (Table  2) and the full length sequences 
of sbCH and sbCL were obtained by SMARTer RACE 
5′/3′ kit (Takara, Japan) according to the manufacturer’s 
instructions.
siRNA against sbCH (siCH) and sbCL (siCL) were 
designed based on the full-length mRNA sequences 
(accession Num: KX989459, KX989460) using the 
online tools siRNA Wizard v3.1 [48] and siDirect V2.0 
[49]. siRNA with an irrelevant sequence to all known 
genes (siIR) were also designed and the sequences of 
the sense and antisense siRNA strands were displayed 
in Table  2. T7 RiboMAX™ Express RNAi System (pro-
mega) was used to synthesize siRNA by in  vitro tran-
scription according to the manufacturer’s instructions. 
siRNA against the same target were used as an equally 
mixed pool in transfection experiments. Pools containing 
300  nM siRNA of sbCH, sbCL or siIR were transfected 
into SB cells using Lipofectamine® 2000 Transfection 
Reagent (Invitrogen) according to the manufacturer’s 
instructions, respectively. The RNA level of clathrin was 
tested by quantitative RT-PCR to evaluate the silence effi-
ciency before the VLP entry assays were performed.
Immunofluorescence assay
Cells were washed twice with PBS, fixed with 4% para-
formaldehyde for 15  min, permeated with 0.2% Triton 
X-100 for 10  min, and then blocked with 5% BSA for 
1 h. Cells were incubated at 4 °C overnight with primary 
antibodies such as mouse anti-VLP sera (polyclonal anti-
body produced in-house, total immunoglobulin) or goat 
anti-biotin monoclonal antibody at 2000-fold dilutions. 
Table 1 The preparation details of all drugs used in this 
study
All drugs used in this study are listed.
a  ST means storage temperature.
b  WC indicates the working concentrations used in this study.
c  MC indicates the max concentration that can be used without cytotoxicity.
Drug Solventt ST (°C)a WC(μM)b MC(μM)c
Chlorpromazine ddH2O 4 1, 7, 70 700
Dynasor DMSO 4 1, 10, 80 800
M-β-CD ddH2O 4 500, 1000, 2000 2000
Genistein DMSO −20 10, 50, 100 100
Wortannin DMSO −20 1, 10, 50 50
ML-7 DMSO −20 1, 20, 40 40
NSC23766 DMSO −20 1, 20, 40 40
Rottlerin DMSO 4 1, 20, 40 40
IPA-3 DMSO −20 1, 20, 40 40
Chloroquine ddH2O 4 10, 100, 1000 1000
NH4Cl ddH2O 4 1000, 5000, 50 000 50 000
Cytochalasin D DMSO −20 1, 10, 77.8 77.8
Wiskostatin DMSO −20 1, 10, 50 50
Nocodazole DMSO −20 1, 10, 50 160
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Subsequently cells were washed three times with PBS for 
15 min and incubated for 1 h at room temperature with 
secondary antibodies such as Alexa Fluor 488 donkey 
anti mouse IgG or Alexa Fluor 594 donkey anti goat IgG 
at 4000-fold dilutions. Cell nuclei were labeled with DAPI 
(1:1000, Sigma) diluted in PBS for 10 min and then cells 
were washed three times with PBS. For identification 
of entry and trafficking of RBS in cells, images were 
acquired using a laser scanning confocal fluorescence 
microscope (TCS-SP5, Leica Microsystems Wetzlar 
GmbH Inc., Germany). Images were acquired randomly 
from 5 different fields of view per coverslip to get more 
than 20 cells and to allow observing the signals of targets 
and nuclei fluorescence by Leica Application Suite (2.6.0 
build 7266). For real-time tracking of CGV, a fluorescent 
inverted microscope (Nikon Eclipse Ti-U, Japan) was 
used to continuously acquire images utilizing Nikon NIS 
Elements imaging software (Br2 v3.21). All experiments 
were performed in triplicate. The results are expressed as 
the mean ± standard deviation (SD).
ELISA
Six wells of cells in a 96-well plate treated with the same 
condition in entry assays were washed thoroughly with 
PBS, lysed with 20 μL of lysis buffer in each well and com-
bined as one sample. Endogenous β-actin was used as an 
internal normalization control for ELISA. Three-hundred 
microliters of 30-fold diluted lysate for VLP detection or 
100-fold diluted lysate for β-actin detection were coated 
equally in three wells of a 96-well microtiter plate at 4 °C 
overnight, respectively. The plate was conducted to room 
temperature and washed three times with 200  μL PBS. 
After blocking with 5% bovine serum albumin (BSA) 
in PBS for 1  h at room temperature and washing three 
times (all washes below indicate triplicate washings) 
with 200 μL PBS containing 0.05% Tween20 (PBST), the 
plate was incubated with in-house produced mouse anti-
VLP antiserum at a dilution of 1:2000 in PBS for 1 h. The 
plate was washed and peroxidase-conjugated goat anti-
mouse IgG (Sigma) at a dilution of 1:3000 in PBS was 
added and incubated for 1 h. Following thorough wash-
ings (five times), 100 μL of OPD substrate (Sigma) was 
added and the color development was conducted at room 
temperature. The reaction was stopped by the addition 
of 4 M sulfuric acid and the absorbance at 492 nm was 
determined. The OD492 of each sample including treated 
and untreated cells was normalized with the correspond-
ing OD492 of β-actin to obtain the relative VLP quantity. 
The entry efficiency was generated as the percentage of 
treated cells with incorporated VLP relative to that for 
untreated cells. The VLP entry efficiency of untreated 
cells was arbitrarily set as 100%. The data shown are the 
mean ± SD of the results from three independent experi-
ments. Statistical differences of VLP content from dif-
ferent groups were assessed by paired Student’s t tests. 
Numerical results are presented as mean ± SD with 95% 
confidence intervals and p < 0.05 was considered statisti-
cally significant (*, p < 0.05; **, p < 0.01).
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Results
The kinetics of VLP entry into SB cells
It has been demonstrated that RBS and CGV can enter 
SB cells rapidly as the native virus [46]. Moreover, 
DGNNV VLP can block the cell attachment and infec-
tion of native virus [45]. We speculated that VLP use the 
same receptor(s) to enter cells as the native betanodavi-
rus, suggesting that VLP and native viruses enter cells 
through the same pathway. To study the dynamics of VLP 
entry, CGV was used to track the locations of VLP in SB 
cells by fluorescent microscopy during different entry 
times. After incubation with CGV at 4  °C for 30  min, 
the cells were plated rapidly at 28  °C to initiate entry. 
The cells were observed at the indicated time points (0, 
10, 20, 30, 60, 90, 120, and 240 min) without fixation. As 
shown in Figure 1, CGV entry into SB cells is a quick pro-
cess similar to the wild-type OGNNV [44]. CGV bound 
to the cell plasma membrane without endocytosis at 4 °C 
(Figure 1A, 0 min). Entry was rapidly initiated when the 
temperature was increased to 28 °C (Figure 1B, 10 min), 
followed by a time-dependent increase of fluorescent 
signal in the cytoplasm with increasing entry times (Fig-
ures  1B–G, 10–120  min). CGV gathered around the 
nucleus after 1 h post-invasion (hpi) (Figure 1E). The flu-
orescent intensity of CGV remained similar between 1.5 
(Figure 1F) and 4 hpi (Figure 1H), suggesting that CGV 
entry was complete within 120 min after attachment. The 
entry process of CGV was from cell plasma membrane 
to perinuclear spot-shape areas. Interestingly, CGV was 
likely to diffuse from perinuclear areas after 4 hpi when 
compared with the CGV location at 120 min (Figure 1G).
The quantities of entered VLP at different time points 
were also evaluated by ELISA and the entry kinetics of 
CGV was determined. The percentage of CGV entry of 
SB cells increased rapidly within 10 min (24%), reaching 
the half-maximal level (50%) at 30  min, and plateauing 
Figure 1 The entry process and the entry kinetics of CGV in SB cells. The entry process of CGV. CGV entry was performed on SB cells as men-
tioned above and at indicated times, 0 (A), 10 (B), 20 (C), 30 (D), 60 (E), 90 (F), 120 (G), and 240 min (H) after entry start, live cells were visualized by 
fluorescent microscopy to locate the CGV position. The bar in E indicates 25 μm. I The entry kinetics of CGV. CGV entry was performed as mentioned 
above and at the indicated times, cells were lysated for ELISA to evaluate the CGV quantity.
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after 90 min (Figure 1I). According to the fluorescent and 
ELISA results of CGV entry, the entry process is quick.
Clathrin‑mediated endocytosis is involved in RBS entry
To identify the endocytosis pathway involved in RBS 
entry, cell perturbation assays of biochemical inhibition 
were performed to evaluate the effect on VLP entry. All 
biochemicals used were tested on SB cells by cytotoxic-
ity assays to obtain the maximum working concentration 
(Table 1).
During CME, CCP assemble on the cytoplasmic side 
of the plasma membrane in response to internaliza-
tion signals from the receptor. The cationic amphiphilic 
agent CPZ inhibits CME by causing misassembly of CCP 
[50]. Therefore, CPZ was used to analyze the role of the 
CME pathway during RBS entry into SB by adding differ-
ent concentrations of CPZ. The RBS in cells were deter-
mined by IFA. As shown in Figure 2A, CPZ significantly 
reduced the fluorescent signal of RBS compared with 
no treatment cells from 1 to 70  μM. In addition, CPZ 
reduced the absolute number of viral particles reach-
ing the perinuclear area. Through ELISA quantitation, 
we found that the VLP entry efficiency was significantly 
decreased to 5% at 70 μM, the highest working concen-
tration of CPZ (Figure 2C). That is to say, 95, 80, and 70% 
VLP were inhibited to enter into SB cells by 70, 7, and 
1 μM CPZ, respectively. The effect of CPZ on VLP entry 
was dose-dependent.
Dynamin is a cellular GTPase which is essential for 
CCV formation and is required for membrane budding 
at a late stage during the transition from a fully formed 
pit to a pinched-off vesicle. Dynasore acts as a potent and 
specific inhibitor of dynamin by rapidly blocking coated 
vesicle formation within seconds of dynasore addi-
tion [51]. We therefore used different concentrations of 
dynasore (1, 10, and 80 μM) to treat SB cells to validate 
the role of dynamin in VLP entry. The fluorescent signals 
were significantly reduced in dynasore-treated cells (Fig-
ure 2B) and the VLP entry efficiency was greatly reduced 
in the presence of dynasore (Figure  2D) in a dose-
dependent manner (71.4, 48.5, and 40%).
Since we obtained the preliminary result that CME 
is involved in RBS entry, cell perturbation assays using 
siRNA silencing were performed to knockdown the 
expression of the SB cell clathrin heavy chain (sbCH) 
and light chain-A (sbCL) to evaluate the dependence of 
clathrin for VLP entry. The cDNA sequences of sbCH 
and sbCL were cloned and sequenced (accession Num: 
KX989459, KX989460). BLAST homology and SMART 
analysis showed that the deduced amino acid sequences 
of sbCH and sbCL matched well with the clathrin from 
other species. Their predicted domains also shared 
similar architectures with other species as shown in 
Additional file 1. The siRNA specific to sbCH (siCH) and 
sbCL (siCL) were designed (Table  2) and synthesized. 
The siRNA for non-inhibition control with an irrelevant 
sequence (siIR) to any available data were also included. 
The siRNA were first transfected into SB cells for testing 
silence efficiency. siCH and siCL decreased the expres-
sion of sbCH and sbCL more than 50%, respectively 
(data not shown). After 48 h post-transfection, VLP entry 
assays were performed on transfected SB cells that were 
either fixed for IFA or collected for ELISA. As shown 
in Figure 2E, the fluorescent signal of VLP in siCH and 
siCL transfected cells were reduced, whereas that in siIR 
transfected cells was similar to the untreated control. The 
silencing of sbCH and sbCL also greatly reduced the VLP 
entry efficiency to 28.5 and 42.8% respectively compared 
with the siIR control (Figure  2F). Taken together, these 
results establish that dynamin-dependent and CME are 
involved in RBS entry into SB cells.
RBS entry is dependent on fluidity of cholesterol but is not 
involved with caveolae/raft‑dependent endocytosis
Cholesterol is very important to the caveolae/raft-
dependent endocytosis. Thus, the chemical agents fil-
ipin, nystatin, or methyl-b-cyclodextrin (MβCD) that 
can sequester or deplete cholesterol from the plasma 
membrane are usually used to inhibit the virus entry into 
cells through caveolae/raft-dependent endocytosis [1]. 
However, cholesterol is also an essential factor to CME. 
Cholesterol can regulate the fluidity of plasma mem-
brane, which can affect formation of CCV. We therefore 
pretreated the SB cells with different concentrations of 
MβCD before VLP entry assay to investigate whether 
RBS entry is dependent on cholesterol. As expected, 2, 1, 
and 0.5 mM MβCD inhibited 74.4, 59.5, and 63.6% RBS 
entry into SB cells, respectively (Figure  3A). We found 
that most parts of RBS stayed outside of plasma mem-
branes in high concentration MβCD-treated cells. By 
contrast, a small amount of RBS reached the perinuclear 
area (Figure  3A, 2  mM) compared with no treatment 
control.
To confirm that the inhibitory effects for RBS entry 
were caused by cholesterol depletion, cell membrane 
cholesterol was replenished with high concentration of 
exogenous cholesterol, and the recovery of RBS entry 
was analyzed. In this replenishing experiment, CGV 
was used to perform VLP entry and was directly visual-
ized by fluorescent microscopy after cell fixation. There-
fore, the fluorescent signal of CGV is relatively weaker 
than that of RBS in IFA. As shown in Figure 3B, almost 
all of the CGV particles were settled on the plasma 
membrane of MβCD-treated cells at the high concen-
tration (5  mM). Cholesterol-depleted cells (pretreated 
with 5  mM  MβCD) were incubated with exogenous 
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Figure 2 RBS entry depends on CME and dynamin. A–D CPZ and dynasore reduce the entry and trafficking of RBS to the perinuclear region of 
SB cells. SB cells were pretreated with CPZ or dynasore at the indicated doses for 1 h, or left untreated, then incubated with RBS for 2 h, and fixed for 
IFA (A, B) or collected for ELISA (C, D). In the untreated or mock-infected controls, cells were subjected to no inhibitor treatment or no RBS incuba-
tion respectively. RBS (green) in cells were visualized by IFA and cell nuclei (blue) were stained by DAPI. The entry efficiency was examined by ELISA 
and the data shown are the mean ± SD of the results from three independent experiments. E, F Inhibition of sbCH and sbCL by RNAi reduced the 
entry of RBS. siRNA specific to sbCH (siCH), sbCL (siCL) and siRNA with irrelevant sequence (siIR) were transfected to SB cells 48 h prior to VLP entry 
assay. After the entry assay, cells were fixed for IFA (E) or collected for ELISA (F). The bars in (A, B, E) indicate 25 μm. *, p < 0.05, **, p < 0.01.
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Figure 3 VLP entry is dependent on fluidity of cholesterol but is not involved with caveolae/raft-dependent endocytosis. A Depletion 
of cholesterol from the plasma membrane inhibited RBS entry. SB cells were pretreated with MβCD at the indicated doses for 1 h prior to incubation 
with RBS. VLP entry assays, IFA, fluorescent microscopy and ELISA were performed. B Cholesterol replenishment partially recovered CGV entry. High 
concentration (5 mM) MβCD-treated cells were incubated without or with exogenous cholesterol for 1 h followed by CGV entry assay. After fixation, 
fluorescent microscopy was performed directly to determine the CGV location. ELISA was also performed to show the entry efficiencies in different 
treatments. C, D Block of the tyrosine kinase signal by genistein and PI3/4 K activity by wortmannin did not inhibit RBS entry. Inhibitors of genistein 
(C) and wortmannin (D) at indicated concentrations were used to treat SB cells followed by RBS entry. For A, C, and D, RBS (green) in cells were visu-
alized by IFA and cell nuclei (blue) were stained by DAPI. The entry efficiency was examined by ELISA and the data shown are the mean ± SD of the 
results from three independent experiments. E RBS entry is dependent on cholesterol but not on sphingolipids. B-CTB and RBS were simultaneously 
incubated with SB cells to perform entry assay for 4 h and their subcellular localization were determined by IFA using anti-biotin (α-biotin, green) 
and anti-VLP (α-VLP, red) as primary antibody. The outline of the cell was indicated by the white line. The merge panel displayed that most of B-CTB 
and VLP were localized in different subcellular locations. F CGV entry is dependent on fluidity of cholesterol. CGV entry assays were performed for 
2 h with different additives as indicated above the panels. After being washed and fixed, cells were observed by confocal microscopy. The bars 
indicate 25 μm. *, p < 0.05, **, p < 0.01.
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cholesterol followed by VLP entry assay. The CGV were 
found in cells and on the plasma membrane (Figure 3B). 
The inhibitory effect was partially reversed with choles-
terol replenishment at a concentration of 0.8 μg/μL. The 
entry efficiency of cholesterol replenishment samples 
was restored to a mean of 57% compared with the mock-
treated cells. Interestingly, cholesterol depletion resulted 
in a reduction but not abolishment of CGV entry. By con-
trast, the supplement of cholesterol in no MβCD-treated 
cells did not enhance the entry of CGV. CGV entry may 
also occur at low cholesterol levels, but increased choles-
terol shows no difference of this process.
Endocytosis via caveolae is dynamin dependent, sen-
sitive to cholesterol depletion, and associated with 
signaling events. In this case RBS entry is dependent 
on dynamin and cholesterol. Thus, whether the entry 
involved caveolae/raft-dependent endocytosis should 
be identified. The effects of genistein and wortmannin 
on VLP entry were determined as caveolae budding is 
regulated by reversible phosphorylation [52]. Previous 
research on ISKNV [17] and tiger frog virus (TFV) [53] 
showed that signal induction is important for viral entry. 
Genistein, a tyrosine kinase inhibitor, blocks the sig-
nals induced by ISKNV and TFV. Thus, we determined 
whether this chemical was also capable of blocking the 
entry of RBS. As shown in Figure 3C, the genistein treat-
ment did not block VLP entry even at a high concentra-
tion (100 μM). The entry quantity of VLP (88%) exhibited 
no significant difference when compared with mock-
treated control. This result indicates that the transmem-
brane signaling is not important for RBS entry into SB 
cells.
The inhibitory regulative G protein (Gi)-coupled recep-
tor was found abundantly in caveolae. Moreover, the 
activation of the Gi-coupled Src kinase pathway plays an 
important role in the formation and migration of endo-
cytosis vesicles in the caveolae/rafe-dependent pathway 
[54]. Wortmannin was used as an inhibitor specific to 
phosphoinositide 3/4-kinase (PI3/4K) leading to reduc-
tion of PI3P content. PI3K/Akt Signal pathway is very 
closely correlated with the caveolae/raft-dependent 
endocytic pathway. PI3K is also a phospholipid kinase, 
such as PI(3,4)P, PI(4,5)P2. Some studies report that 
these phospholipids are regulators of CME [1]. Thus, 
SB cells were treated with different concentrations of 
wortmannin and VLP entry assays were performed. As 
shown in Figure 3D, 50, 10, and 1 μM wortmannin could 
block 23.0, 0.82, and −1.4% RBS entering into SB cells 
compared with the mock-treated control. Inhibition of 
PI3/4K activity exhibits no perceptible effect on prevent-
ing RBS entry.
Lipid rafts are subdomains of the plasma membrane 
that contain high concentrations of cholesterol and 
sphingolipids. CTB binds to the sphingolipid GM1, 
which is a marker to identify lipid rafts [55]. To further 
illustrate the endocytosis of RBS, clathrin-independ-
ent and cholesterol-sensitive CTB [52] was used as the 
control for subcellular localization via caveolae/raft-
dependent endocytosis. Biotin conjugated CTB (B-CTB) 
and RBS were simultaneously incubated with SB cells to 
perform the entry assay for 4 h. Their subcellular locali-
zations were determined by IFA using anti-biotin and 
anti-VLP antibodies as primary antibody. As shown in 
Figure  3E, both B-CTB (green) and RBS (red) stayed at 
the perinuclear area. However, a few of them were co-
localized as indicated in the merged panel. This result 
revealed that both B-CTB and RBS entries required lipid 
rafts, in which B-CTB needed sphingolipids and VLP 
depended on cholesterol, and they used different endocy-
tosis pathways. Therefore, RBS entry is not involved with 
caveolae/raft-dependent endocytosis.
Based on the above results, we found that RBS entry 
is clathrin-dependent but caveolin-independent, 
cholesterol-depletion sensitive but insusceptible to 
replenishment, and not co-localized with sphingolip-
ids. Accordingly, we presumed that VLP entry may be 
mediated by the protein receptor(s) located at lipid rafts 
or even use specific lipids as the receptor. The fluidity 
of cholesterol and sphingolipids is important for VLP 
entry because the binding of the receptors and their 
ligands (virus or toxin) and their internalization are 
sensitive to the fluidity of the plasma membrane [56]. 
Components of lipid rafts maintain certain mobility on 
the plasma membrane. For example, individual ganglio-
sides diffuse in the plasma membrane of cells at a diffu-
sion constant in the range of a few mm2/s, interaction 
with cholesterol leads to short-lived confinement in the 
nanometer range [57], and the binding of CTx to GM1 
strongly reduces the diffusion of other lipid molecules 
in the same membrane as well as increases the melt-
ing temperature of supported membrane bilayers [28]. 
Thus, we used B-CTB to bind the raft-resident ganglio-
side GM1 and anti-biotin antibodies were used to bind 
B-CTB, mediating blockage of B-CTB entry and reduc-
tion of lipid raft fluidity. At the same time, entry assays 
using CGV were performed to evaluate the influence 
to CGV movement at low fluidity of plasma membrane 
lipids. After 2 h of CGV entry assays with different addi-
tives as indicated in Figure 3F, cells were washed exten-
sively, fixed, and checked by confocal microscopy. As 
expected, most of the CGV stayed at the plasma mem-
brane with little entry when B-CTB and anti-biotin anti-
body were added together (Figure  3F, right panel). By 
contrast, the cells without antibody and with CGV plus 
B-CTB (Figure 3F, left panel) showed the normal entry 
property of CGV. The cells with CGV and anti-VLP 
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antibody (Figure 3F, middle panel) exhibited the mem-
brane settlement of the blocked CGV. In summary, RBS 
entry is dependent on fluidity of cholesterol but is not 
involved with caveolae/raft-dependent endocytosis. 
However, the entry receptor(s) for OGNNV is worthy of 
further study.
Entry of RBS is independent of macropinocytosis
Besides the clathrin- and caveolae/raft-dependent 
endocytic processes, macropinocytosis has received 
increasing attention because of its roles in immune 
defense and virus entry [2]. Increasing numbers of 
studies have reported that macropinocytosis requires 
signaling events, especially in the uptake of virus par-
ticles. During influenza virus entry, a functional acto-
myosin network and the activation of p21-activated 
kinase 1 (PAK1) are essential for macropinocytosis, 
while EV1 and vaccinia virus entry via macropinocy-
tosis depend on PAK1 and protein kinase C (PKC) [58, 
59]. A previous report demonstrated that macropi-
nocytosis is an important route for the cellular entry 
of DGNNV [41]. Therefore, in our study, ML-7 was 
used to antagonize the phosphorylation of myosin 
light chain kinase to regulate myosin II activity, and 
NSC23766 was used to specifically inhibit Rac1 activ-
ity without affecting the closely related Rho-GTPases. 
We also used rottlerin and IPA-3 to inhibit PKC and 
PAK1 activities in SB cells, respectively. As shown 
in Figure  4A, rottlerin (R), IPA-3 (I), ML-7 (M), and 
NSC23766 (N), all exhibited no statistically signifi-
cant change on the percentage of RBS entry efficiency 
whereas CPZ (C), the inhibitor for CME, dramatically 
reduced the entry efficiency compared with that of 
untreated cells (+). The locations of entered RBS in 
these four inhibitor treated cells were similar to that in 
untreated cells (data not shown). These results suggest 
that multiple signaling molecules were not involved 
in RBS entry, which agree with the results of kinase 
inhibitors, genistein and wortmannin.
Although the inhibitors of macropinocytosis do not 
block RBS entry with significant difference compared 
with the untreated cells, a certain reduction can be seen 
in samples treated with rottlerin, IPA-3, and ML-7. The 
compensatory activation of alternative pathways may 
appear when one pathway is closed down [1]. There-
fore, we tried to determine whether a statistical differ-
ence exists when inhibitors of macropinocytosis and 
CME are used simultaneously. As shown in Figure  4B, 
no obvious difference was observed between the entry 
efficiency in CPZ-treated cells and the CPZ plus macro-
pinocytosis inhibitor-treated cells. In summary, these 
results indicate that entry of RBS is independent of 
macropinocytosis.
RBS entry is pH dependent
Once internalized within the primary endocytic vesi-
cles, many viruses follow the intracellular pathways of 
the endosomal system which is responsible for molecular 
sorting, recycling, degradation, storage, and processing 
[1]. In the endosomal system, a gradual drop in inter-
nal pH occurs from mild acidity (pH 6.5–6.0) in early 
endosomes to values below 5 in endolysosomes. Virus 
entry via CME is sensitive to pH changes, indicating the 
importance of low pH for viral infection [60]. To further 
analyze the role of low pH in RBS entry, lysosomotropic 
agents, such as chloroquine and NH4Cl, the chemical 
inhibitors for endosomal acidification, were used to treat 
SB cells. As shown in Figure 5, different concentrations of 
chloroquine and NH4Cl significantly decreased the VLP 
entry efficiency compared with no treated cells. The high 
concentration of chloroquine (1  mM) can totally block 
the entry (Figure 5A). Interestingly, most of the entered 
RBS in treated cells were stuck in the vesicle-like spots 
that were larger than the small dots in untreated cells 
(Figure  2A). VLP quantitation revealed that 0.01  mM 
chloroquine can block more than 70% RBS. In addition, 
1 mM chloroquine can totally block VLP entry, conform-
ing to the IFA results. Up to 50 mM NH4Cl can reduce 
Figure 4 Entry of RBS is independent of macropinocytosis. A 
Inhibitors of macropinocytosis were used individually. B Inhibitors of 
macropinocytosis and CME were used simultaneously. All inhibitors 
of macropinocytosis (40 μM) including Rottlerin (R), IPA-3 (I), ML-7 
(M), and NSC23766 (N), and CME inhibitor (7 μM) CPZ (C) were used, 
alone or overlay as indicated +, to treat SB cells for 1 h. Two hours 
of VLP entry assays with the inhibitors and the following ELISA were 
performed. RBS entry without inhibitor was served as the untreated 
control (+). *, p < 0.05, **, p < 0.01.
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the VLP entry efficiency to 25% (Figure 5B). These results 
demonstrate that RBS enter SB cells in a pH-dependent 
manner.
RBS entry is dependent on the cytoskeleton
Upon internalization, viruses are usually delivered 
to endosomal compartments and transported to the 
replication sites along actin filaments/microtubules 
[61, 62]. To determine the roles of actin filaments/
microtubules during RBS entry, several chemical 
inhibitors were used as follows. CytD inhibits actin 
filament elongation at the barbed end and wiskostatin 
blocks neuronal Wiskott-Aldrich syndrome protein 
(N-WASP) activity by stabilizing its autoinhibited con-
formation, thus leading to a significant decrease in the 
rate of actin polymerization [63]. Nocodazole depo-
lymerizes microtubules by preventing the formation of 
one of the two interchain disulfide linkages. As shown 
in Figure 6, disruption of actin dynamics by CytD and 
wiskostatin significantly reduced the total number of 
RBS entered in SB cells. Up to 77.8, 10, and 1 μM CytD 
can block 96.5, 96.0, and 83.2% RBS entry into SB cells, 
respectively (Figure 6A). By contrast, 50, 10, and 1 μM 
wiskostatin can block 94.2, 84.6, and 77.9% RBS entry 
into SB cells, respectively (Figure 6B). It is worthwhile 
to note that most VLP stayed around the plasma mem-
brane in 50 μM wiskostatin treated cells although the 
inhibition of entry efficiency was lower in wiskostatin 
treated samples than in CytD treated samples. Fur-
thermore, we treated SB cells with nocodazole. The 
results revealed that 50, 5, and 1  μM nocodazole can 
block 81.3, 74, and 59.4% RBS entry into SB cells (Fig-
ure 6C). These results suggest that RBS entry into SB 
cells is dependent on cytoskeleton of actin filaments 
and microtubules.
RBS enter NNV‑sensitive cells via CME
Virus-like particles are robust protein cages that mimic 
the overall structure of the native virions but lack the 
viral genome. They are often antigenically indistinguish-
able from the native virus but the entry performance 
might be slightly different with native virus [64]. To 
determine the entry property of RBS, VLP entry assay 
and IFA were used to screen several types of cell lines 
including fish, mammals, and insects. A total of 10 cell 
lines were used for screening, namely, SSN-1, GB, FHM, 
EPC, MFF, Hela, 293T, BHK, Sf9, and S2. The entry assay 
and IFA revealed that RBS only entered SSN-1 and GB 
cells (Figure 7) that are sensitive to NNV infection (per-
sonal communications) but did not enter other tested cell 
lines even the fish cell lines (data not shown). The results 
suggest that the entry property of RBS is similar to that of 
native NNV.
Since we confirmed that CME is involved in RBS entry 
into SB cells as well as RBS only entering SSN-1 and GB, 
we determined the VLP endocytosis pathway in SSN-1 
Figure 5 Inhibition of endosomal acidification prevents RBS entry. SB cells were treated with chloroquine (A) or NH4Cl (B) at the indicated 
doses for 1 h. VLP entry assays, IFA, fluorescent microscopy, and ELISA were performed. RBS (green) in cells were visualized by IFA and cell nuclei 
(blue) were stained by DAPI. The entry efficiency was examined by ELISA and the data shown are the mean ± SD of the results from three inde-
pendent experiments. The bars indicate 25 μm. **, p < 0.01.
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and GB. During the entry assay, we found that RBS 
entered into SSN-1 and GB cells quickly and reached the 
perinuclear regions within 90  min (Figure  7). Further-
more, CPZ was used to analyze the role of CME during 
RBS entry into SSN-1 and GB cells. As shown in Figure 7, 
VLP entry efficiencies in CPZ treated samples dramati-
cally decreased when compared with untreated samples. 
This result suggests that RBS entered SSN-1 and GB cells 
via CME. In other words, RBS entry into NNV-sensitive 
cells is dependent on CME.
Discussion
Viruses use endocytosis to effectively enter host cells and 
then transport to suitable endosomes or other intracel-
lular organelles for the subsequent genome release or 
replication. Studying virus entry pathways is important 
to understand viral pathogenesis and to develop effective 
drugs to block virus infection at the very early and criti-
cal step, that is, virus entry [1].
In research on virus entry, besides native virus, recom-
binant or modified viruses and VLP are also used [33, 41, 
65]. VLP can be produced eukaryotically and prokary-
otically, and can also be easily modified by genetic engi-
neering. Therefore, the high stability of genetics and 
production can be confirmed, avoiding the low-mutation 
rate occurring in wild-type virus [44]. Furthermore, the 
advantages of easy and large production of VLP are ben-
eficial to perform parallel experiments using multiple 
chemical inhibitors at the same time. As a result, cred-
ible data on the situation of equal status of culturing cells 
can be obtained. Although detecting the expression of 
the viral gene at a certain period after native virus infec-
tion in the entry perturbation assay is a highly sensitive 
method, it is difficult to distinguish whether effective 
blocking is due to entry inhibition or because of late-
stage virus replication inhibition [1]. In this study, we 
replaced native virus with RBS and CGV (modified VLP) 
to perform the entry assay. VLP can show the entry status 
Figure 6 RBS entry into SB cells is dependent on cytoskeleton. SB cells were treated with chemical inhibitors of CytoD (A), wiskostatin (B), 
and nocodazole (C) respectively at the indicated doses for 1 h. VLP entry assays, IFA, fluorescent microscopy, and ELISA were performed. RBS (green) 
in cells were visualized by IFA and cell nuclei (blue) were stained by DAPI. The entry efficiency was examined by ELISA and the data shown are the 
mean ± SD of the results from three independent experiments. The bars indicate 25 μm. **, p < 0.01.
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on quantity and location as well as avoid the long time 
wait when detecting viral gene expression after infection. 
Nevertheless, between RBS/CGV and authentic NNV, 
maybe there are some slight differences which might 
affect the sophisticated research on virus entry and entry 
receptor. In the study of RBS, we proved that the entry 
ability of RBS/CGV is the same as native NNV. Therefore, 
the RBS-SB cell entry model is reliable and stable.
Macropinocytosis is one of the pathways during virus 
entry of DGNNV [41]. In the RBS-SB model, we proved 
that macropinocytosis is not involved in RBS entry into 
SB cells. This result is proven by biochemical perturba-
tion assays regardless of using macropinocytosis inhibi-
tors only or overlay using the CME inhibitor. We also 
screened 10 more cell lines from different species by 
VLP entry assays. We demonstrated that RBS can only 
enter NNV-sensitive cells and mainly by CME. Moreo-
ver, in another NNV receptor relative study, the earliest 
detection time point for gene expression was set to 1  h 
post-infection [40], indicating that NNV entry is a quick 
process in accordance with the characteristic of CME. 
We also believed that a minor portion of RBS enters SB 
cells via macropinocytosis but that portion is predicted 
below 1% of all entered virus. This result was consistent 
with the fact that RBS is soaked randomly by the normal 
cell macropinocytosis.
The structure and composition of virus are simple but 
their interactions with host cells are complex, especially 
the entry process. Besides endocytic pathways, some cell 
components or conditions are essential for successful 
virus entry [1]. In our study, the entry of RBS into SB 
cells was significantly and dose-dependently reduced by 
treatment with CPZ and dynasore as the key inhibitors 
for CME. Furthermore, the VLP entry efficiency was also 
dramatically decreased by silencing the SB clathrin heavy 
and light chains. We basically confirmed that RBS enter 
SB cells mainly via CME depending on dynamin-2.
Lipid rafts are involved in many cellular processes, such 
as endocytosis, signaling, protein sorting, and intracellu-
lar membrane trafficking. Sphingolipids are a major class 
of membrane lipids and are also involved in the stabil-
ity of the lipid scaffold of lipid enriched microdomains 
as a bulk lipid. Cholesterol is a ubiquitous component of 
eukaryotic cell plasma membrane and is central to the 
organization, dynamics, function, and sorting of lipid 
bilayers in vivo [66]. In our study, cholesterol is not only 
essential for RBS/CGV entry as demonstrated in assays 
of cholesterol depletion and replenishment but also its 
fluidity is necessary for effective RBS entry as shown in 
B-CTB binding assay. In the depletion and replenish-
ment assays, we can observe that the depletion of cho-
lesterol cannot abolish RBS entry and the replenishment 
of cholesterol can only partially recover the depletion 
of MβCD. The excess cholesterol cannot enhance CGV 
entry, suggesting that the quantity of cholesterol is not 
the most important factor during VLP entry. Therefore, 
we suspected that the fluidity of cholesterol is the key 
element. B-CTB and anti-biotin antibody were spon-
taneously used to decrease the fluidity of sphingolipid, 
eventually reducing the cell membrane fluidity [28, 56]. 
The results show that RBS entry was blocked and mainly 
stayed at plasma membrane when anti-biotin antibody 
was present, demonstrating that the low fluidity of lipid 
raft greatly reduced RBS entry. Accordingly, the fluidity 
of cholesterol on plasma membrane is crucial for RBS 
entry. Furthermore, the cellular localizations of RBS and 
B-CTB were largely not the same, suggesting the different 
endocytic pathways and intracellular trafficking routes 
of RBS and CTB. The result also verified that caveolae/
raft-dependent pathways mediate the internalization 
of sphingolipids and sphingolipid-binding toxins, such 
as CTB as indicated in previous studies [52]. Actually, 
RBS entry requires cholesterol and membrane fluidity is 
closely related to the cellular receptor(s)-mediated virus 
entry. Previous studies showed that the functional cellu-
lar components including HSP70 [40] and extracellular 
sialic acid [41] are required for active NNV infection. In 
addition, we performed the experiment that extracellular 
components of SB cells were destroyed by several rea-
gents before the VLP entry assay. The results show that 
only the treatments of protease K and neuraminidase can 
block RBS entry (unpublished data). It can be deduced 
Figure 7 RBS enters GB and SSN-1 cells via CME. VLP entry assay, 
IFA and fluorescent microscopy were performed on ten cell lines and 
RBS can only enter GB and SSN-1 as indicated in VLP + panels. To 
identify the endocytic pathway, GB and SSN-1 cells were pretreated 
with CPZ for 1 h. VLP entry assay, IFA and fluorescent microscopy 
were performed and RBS entry was dramatically decreased in VLP +/
CPZ + samples. RBS (green) in cells were visualized by IFA and cell 
nuclei (blue) were stained by DAPI. The bars indicate 25 μm.
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that the most important component on the cell surface 
mediating virus entry is protein with sialic acid modifi-
cation. Therefore, the cellular entry receptor for NNV 
is basically glycoprotein. It is worthy of further study to 
determine whether the low fluidity of lipid raft restricts 
the mobility of entry receptor(s), mediating the blockage 
of NNV entry. Nevertheless, we also cannot rule out the 
possibility that other components in lipid rafts are the 
authentic entry receptor(s) for NNV entry.
Once internalized within primary endocytic vesicles, 
the incoming viruses will follow the intracellular path-
ways, the endosomal system, to the replication sites. 
The pH-dependent endosomal system is responsible for 
molecular sorting, recycling, degradation, storage, pro-
cessing, and transcytosis of incoming substances [1]. 
Therefore, we studied whether RBS entry is dependent 
on low pH after the endocytosis pathway since RBS was 
confirmed to be CME. Our results show that chloroquine 
and NH4Cl, the lysosomotropic weak bases that decrease 
the pH of the endosomal system, can significantly block 
RBS entry, suggesting that RBS is delivered to the peri-
nuclear area through the endosomal system. The inten-
sive studies on the interaction of VLP and endosome 
network and the intracellular trafficking pathway should 
be further investigated. For example, the co-localization 
study of RBS and the markers of the main organelles of 
the endosome network, such as Rab5 (early endosome), 
Rab7 (late endosome), Rab22 (recycling endosome), and 
Rab9 (trans-Golgi network) should be performed [1]. The 
migration of endosomes from peripheral area to the peri-
nuclear area and finally fusion with lysosomes is medi-
ated by the change in the interaction with cytoskeletal 
elements. Thus, the normal function of cytoskeleton is 
fundamental for active virus infection via endocytosis. To 
verify whether RBS entry is dependent on cytoskeleton, 
we used CytD and wiskostatin to disrupt actin dynamics 
and nocodazole to depolymerize microtubules. All these 
three reagents dramatically blocked RBS entry, suggest-
ing that both actin filaments and microtubules are impor-
tant for RBS entry. Interestingly, high concentration 
of wiskostatin (50  μM) inhibited RBS entry but did not 
affect the RBS binding to cells as shown by the plasma 
membrane surface localization of RBS. According to pre-
vious studies [38] and our unpublished data, the genome 
replication of NNV occurred at the virus factory in the 
mitochondria. Therefore, the intracellular trafficking of 
NNV in sensitive cells remains to be fully elucidated.
Betanodaviruses have strong infectivity to a wide range 
of hosts [38, 44]. In this study, we determined the entry 
property of RBS by screening 10 cell lines via VLP entry 
assay and IFA. RBS only entered SSN-1 and GB cells 
that are sensitive to NNV infection but did not enter 
other tested cell lines. This result suggests that the entry 
property of VLP is the same as that of native NNV. For 
Hela and 293T cells, we did not observe the VLP entry 
or attachment in the assays, which was different from 
the results of a previous study showing that red-spotted 
grouper nervous necrosis virus can attach but cannot 
penetrate the cells [67]. Furthermore, the CPZ pretreat-
ment of SSN-1 and GB cells showed that RBS entry sig-
nificantly decreased, indicating a common feature that 
RBS entry into NNV-sensitive cells is dependent on 
CME.
In conclusion, the evidence presented here demon-
strates that RBS enters SB cells via CME, depending 
on dynamin-2, cholesterol and its fluidity, low pH, and 
cytoskeleton. As a virus in the same family and differ-
ent genus, the entry pathway studies of betanodavirus 
are more intensive than that of flock house virus (FHV), 
the representative species of alphanodavirus, because 
the entry studies of FHV focused on the structure trans-
formation of virion during virus-cell interaction and the 
dependency of the acidic endocytic pathway [39]. How-
ever, the specific endocytic pathway and entry receptor(s) 
for FHV are yet to be clearly defined. Aquatic viruses use 
various entry pathways depending on the virus, such as 
frog virus 3 (FV3) [68], SGIV [2] and infectious hemat-
opoietic necrosis virus [69] utilizing CME, TFV [53] and 
ISKNV [17] employing caveolae/raft-dependent endocy-
tosis, indicating the complicated virus-cell interaction. 
The different endocytic pathways used by TFV, FV3 and 
SGIV that are closely related viruses in the same genus 
may be due to different cell lines utilized in entry studies, 
simultaneously suggesting the broad host range of rana-
virus. Nevertheless, in our study, the fact that RBS enters 
both three NNV-sensitive cell lines via CME depending 
on cholesterol indicates the unity of the entry pathway in 
betanodavirus. Further studies are needed to determine 
the detailed mechanisms involved in the entry routes 
for betanodavirus and the specific receptor(s) mediating 
betanodavirus entry.
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